1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014

Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014" provides data on the Polymyalgia Rheumatica clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polymyalgia Rheumatica. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Polymyalgia Rheumatica. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Polymyalgia Rheumatica Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Polymyalgia Rheumatica 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Polymyalgia Rheumatica to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Polymyalgia Rheumatica 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Polymyalgia Rheumatica Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
F. Hoffmann-La Roche Ltd. 27
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 27
Novartis AG 28
Clinical Trial Overview of Novartis AG 28
Mundipharma International Limited 29
Clinical Trial Overview of Mundipharma International Limited 29
Clinical Trial Overview of Top Institutes / Government 30
Hospital San Pietro Fatebenefratelli 30
Clinical Trial Overview of Hospital San Pietro Fatebenefratelli 30
University Hospital, Brest 31
Clinical Trial Overview of University Hospital, Brest 31
University Hospitals Bristol NHS Trust 32
Clinical Trial Overview of University Hospitals Bristol NHS Trust 32
The Hospital Santa Maria Nuova 33
Clinical Trial Overview of The Hospital Santa Maria Nuova 33
St. Vincent's University Hospital 34
Clinical Trial Overview of St. Vincent's University Hospital 34
Saitama Medical University 35
Clinical Trial Overview of Saitama Medical University 35
Bnai Zion Medical Center 36
Clinical Trial Overview of Bnai Zion Medical Center 36
Bispebjerg Hospital 37
Clinical Trial Overview of Bispebjerg Hospital 37
UMC Utrecht Holding BV 38
Clinical Trial Overview of UMC Utrecht Holding BV 38
Five Key Clinical Profiles 39
Appendix 128
Abbreviations 128
Definitions 128
Research Methodology 129
Secondary Research 129
About GlobalData 130
Contact Us 130
Disclaimer 130
Source 130

List of Tables
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Region, 2014* 7
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Polymyalgia Rheumatica Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Polymyalgia Rheumatica Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Polymyalgia Rheumatica Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Polymyalgia Rheumatica Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Polymyalgia Rheumatica to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Polymyalgia Rheumatica Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Polymyalgia Rheumatica Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Polymyalgia Rheumatica Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Polymyalgia Rheumatica Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 27
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 28
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2014* 29
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital San Pietro Fatebenefratelli, 2014* 30
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Brest, 2014* 31
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Bristol NHS Trust, 2014* 32
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital Santa Maria Nuova, 2014* 33
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Vincent's University Hospital, 2014* 34
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014* 35
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Bnai Zion Medical Center, 2014* 36
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by Bispebjerg Hospital, 2014* 37
Polymyalgia Rheumatica Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014* 38

List of Figures
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Polymyalgia Rheumatica Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Polymyalgia Rheumatica Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Polymyalgia Rheumatica Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Polymyalgia Rheumatica to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Polymyalgia Rheumatica Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Polymyalgia Rheumatica Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Polymyalgia Rheumatica Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Polymyalgia Rheumatica Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 25
Polymyalgia Rheumatica Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 26
GlobalData Methodology 129

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.